Vaccination News

A CDC advisory committee voted 10-4 on Wednesday to recommend administering a newly approved pentavalent meningococcal vaccine when vaccination with both a MenACWY and MenB vaccine are indicated at the same visit.

The FDA is set to review what could be the country’s first self-administered influenza vaccine.

An analysis of online conversations among health care professionals on social media during September revealed mixed reactions toward newly updated messenger RNA COVID-19 vaccines.

A new study links some neurocognitive symptoms of long COVID to persistent SARS-CoV-2 infection in the gut, which triggers a series of reactions that lowers serotonin levels.

People infected with COVID-19 have a higher risk of cardiovascular/cerebrovascular complications. However, researchers found that these risks can be reduced with vaccination and boosting.

Vaccine mandates played a significant role in boosting influenza vaccination rates during the 2020-2021 influenza season, researchers reported in Pediatrics.

BOSTON — In this video, Jodie A. Dionne, MD, MSPH, associate professor of medicine at the University of Alabama at Birmingham, recaps her IDWeek presentation on vaccines and sexually transmitted infections.

BOSTON — GSK’s respiratory syncytial virus vaccine had a sustained effectiveness of around 67% among adults aged 60 years or older across two full RSV seasons, researchers reported at IDWeek.

COVID-19 vaccination was associated with a reduced likelihood of long COVID among children infected with SARS-CoV-2 during the omicron wave, according to study findings presented at IDWeek.

BOSTON — Boosting with mRNA-1273 provided additional COVID-19 protection during the delta and omicron waves, and especially among older adults, according to data from the phase 3 coronavirus efficacy (COVE) trial presented at IDWeek.